The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1029601
Abstract: Liver cancer is the third most common cause of cancer-related deaths in the world and has become an urgent problem for global public health. Bioactive substances are widely used for the treatment of liver cancer… read more here.
Keywords: pathogenesis liver; bioactive substances; liver cancer; cancer ... See more keywords
Role of TFEB in Autophagy and the Pathogenesis of Liver Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12050672
Abstract: The transcription factor EB (TFEB) is a master regulator of lysosomal function and autophagy. Mechanistic target of rapamycin (mTOR)-mediated phosphorylation on TFEB is known to regulate TFEB subcellular localization and activity at the lysosomal surface.… read more here.
Keywords: tfeb; pathogenesis liver; liver diseases; role ... See more keywords